期刊文献+

系统性红斑狼疮患者外周血单个核细胞骨调素表达及临床意义 被引量:3

OPN expression of peripheral blood mononuclear cells in systemic lupus erythematosus (SLE) and its clinical significance
原文传递
导出
摘要 的探讨骨调素(osteopontin,OPN)在系统性红斑狼疮(SLE)患者中的表达及临床意义。方法用流式细胞仪和Northernblot杂交方法分别检测SLE患者外周血单个核细胞(PBMC)OPN蛋白和mRNA的表达。结果活动期和稳定期SLE患者PBMCOPN蛋白和mRNA的表达均高于正常人(P<001),SLE患者OPN蛋白主要在淋巴细胞表达,而活动期患者PBMCOPN蛋白及mRNA的表达高于稳定期患者(P<005)。结论SLE患者PBMCOPN表达增高,提示OPN在人类SLE的发病机制中有重要作用,OPN可能作为SLE活动性指标之一。 Objective To investigate osteopontin(OPN)expression in SLE patients and its clinical significance. Methods The OPN protein and mRNA expression in peripheral blood mononuclear cells (PBMC) from 80 patients and 30 healthy persons was detected by cytometry and Northern blot analysis method. Results The OPN protein and mRNA expression of PBMC in SLE patients were significantly higher than in controls (P<001).OPN protein expressin of lymphocyte was significantly higher than that of monocyte in SLE patients.There were significant differences in PBMC protein and mRNA expression between active group and inactive group (P<005). Conclusion OPN abnormal expression in SLE patients suggests that OPN may play an important role in the pathogenesis of SLE.OPN may be considered as a marker for estimating activity of SLE.
出处 《中华风湿病学杂志》 CAS CSCD 1999年第2期84-86,共3页 Chinese Journal of Rheumatology
关键词 系统性红斑狼疮 骨调素 单个核细胞 病理 治疗 Lupus erythematosus,systemicOsteopontin
  • 相关文献

同被引文献24

  • 1楼波,吕晶,郑敏.血浆骨桥蛋白水平与系统性红斑狼疮活动性的关系[J].中华皮肤科杂志,2006,39(6):320-321. 被引量:8
  • 2叶任高.系统性红斑狼疮[M].见:叶任高主编.内科学.第5版.北京:人民卫生出版社,2000:909.
  • 3LIOSSIS S N C, TSOKOS G C. Bcell abnormalities in systematic lupus erythematosus[M]// WALLANCE D J. Hahn BHDubois, lupus erythermotosus. Baltimore: Williams@Wikins, 2001:205-208.
  • 4BLOM T, FRANZEN A, HEINEGAD D, et al. Common on “The influence of proinflammatory cytokine, ostoepontin, on autoimmune demyelinating disease”[J]. Science, 2003,299:1845.
  • 5BOMBANDIER C, GLADMANN D D, UROWITZ M B, et al. The committee on prognosis studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients[J]. Arthritis Rheum, 1992,35(6):630-640.
  • 6KOTZIN B L. Systemic lupus erythematosus [J]. Cell,1996,85 (3):303-306.
  • 7GIGANTE A, AMOROSO D, FERRI F, et al. Systemic lupus erythematosus and renal involvement: which role of citokines expression? [J]. Eur Rev Med Pharmacol Sci, 2006,10(5):223- 228.
  • 8TAN E M, COHEN A S, FRIES J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1982,25(11):1271-1277.
  • 9BOMBARDIER C, GLADMAN D D, UROWITZ M B, et al. Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE [J]. Arthritis Rheum, 1992,35(6):630-640.
  • 10O' REGAN AW,HAYDEN JM,BERMAN JS.Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which resuLts in IL-12 prodution from peripheral blood mononuclear cells[J]. J Leukoc Biol,2000,68 (4):495-502.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部